MetaCap

Metagenomi Therapeutics (MGX) vs Genenta Science S.p.A. (SAEN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Genenta Science S.p.A. is the larger company by market cap ($24.5 million vs $21.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MGX-25.66%SAEN-47.19%
+7%-22%-50%
Nov 3, 20261 yearNov 20, 2026
MGX-20.36%SAEN-23.70%
+1%-12%-25%
Nov 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MGX versus SAEN key metrics
MetricMGXSAEN
Share price$0.565$0.5074
Market cap$21.36M$24.47M
1-day change-7.95%-9.39%
YTD return-65.12%—
1-year return-62.58%—
EPS (TTM)$-2.50$-0.37
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$25.21M—
Revenue growth (YoY)-51.79%—
Net income (latest FY)$-87.87M—
Operating margin-380.85%—
Net margin-348.54%—
52-week high$1.87$2.58
52-week low$0.562$0.50
Distance from 52-week high-69.79%-80.33%
Analyst consensusstrong_buy—
Avg. price target upside+1138.94%—
Average volume163.21K85.01K
Shares outstanding37.81M48.22M
Employees1139
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Metagenomi Therapeutics

MGX stock →

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees

About Genenta Science S.p.A.

SAEN stock →

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees

MGX vs SAEN FAQ

Which is bigger, Metagenomi Therapeutics or Genenta Science S.p.A.?

Genenta Science S.p.A. (SAEN) is larger, with a market capitalization of $24.47M compared with $21.36M for Metagenomi Therapeutics (MGX).

Are Metagenomi Therapeutics and Genenta Science S.p.A. in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons